chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills; Headache; Nasal congestion; body aches; Chest congestion; Very shallow breathing; Cough; she had to walk around a bit and was a little unsteady; This is a spontaneous report received from contactable reporter (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 55 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 23Sep2021 15:00 (Lot number: FE3592) at the age of 55 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Seasonal allergies" (unspecified if ongoing), notes: Onset Date: 12 years old; "anxiety" (unspecified if ongoing); "congestion" (unspecified if ongoing); "Pain" (unspecified if ongoing). Concomitant medication(s) included: MEDROL [METHYLPREDNISOLONE]; ZANAFLEX; CLOBETASOL 0.05%; VAGIFEM; BUSPAR taken for anxiety; ESOMEPRAZOLE; ASPIRIN [ACETYLSALICYLIC ACID]; ZYRTEC [CETIRIZINE HYDROCHLORIDE] taken for nasal congestion; IBUPROFEN taken for pain; TYLENOL taken for pain. Vaccination history included: Flu vaccine (It was last year.), administration date: 2020, reaction(s): "little ache or sore throat". The following information was reported: HYPOPNOEA (non-serious) with onset 23Sep2021 18:00, outcome "not recovered", described as "Very shallow breathing"; COUGH (non-serious) with onset 23Sep2021 18:00, outcome "not recovered", described as "Cough"; GAIT DISTURBANCE (non-serious) with onset 23Sep2021 15:10, outcome "recovering", described as "she had to walk around a bit and was a little unsteady"; CHILLS (non-serious) with onset 23Sep2021 18:00, outcome "recovering", described as "Chills"; HEADACHE (non-serious) with onset 23Sep2021 18:00, outcome "not recovered", described as "Headache"; NASAL CONGESTION (non-serious) with onset 23Sep2021 18:00, outcome "not recovered", described as "Nasal congestion"; PAIN (non-serious) with onset 23Sep2021 18:00, outcome "recovering", described as "body aches"; CHEST DISCOMFORT (non-serious) with onset 23Sep2021 18:00, outcome "recovering", described as "Chest congestion". Therapeutic measures were taken as a result of hypopnoea, cough, gait disturbance, chills, headache, nasal congestion, pain, chest discomfort.  Additional information: The patient reported that she was scheduled to get second one the end of this week and was concerned because she was still having shallow breathing. Patient was concerned and thinks it was typical. Everything was worse on Right side and that is the side she received vaccine on. She also had nasal and chest congestion for a week. The chest has improved because there is nothing there when she coughs.  The nasal congestion is persistent. There was no emergency or physician visit. There was no any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The events require the initiation of new medication or other treatment or procedure.  Follow-up attempts are completed. No further information is expected.
Pt was in observation and had witnessed syncopal event.  Is prediabetic and had not eaten that day.  Witnessed by nurse.  911 called, assessed and transported to hospital.
patient was given the prevnar 13 walked a way for 2 minutes then came back and sat on are bench and said she was feeling dizzy, she also stated that she had been working out for 45 minutes prior to the shot, i told her to sit down for 15 mins, and gave her some cold water, she recovered and felt she was dehydrated from working out and that might have made her dizzy, i called later to check up on her and she recovered fully.
This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of erythema in a subject of unspecified age and gender who was vaccinated with KINRIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of KINRIX (.5 ml, route unknown). At an unspecified time after vaccination with KINRIX, the subject experienced erythema, hardness injection site, swelling injection site and injection site warmth. At the time of reporting the outcome of the events was unspecified. The healthcare professional considered the events were possibly related to vaccination with KINRIX. This case corresponds to a pharmaceutical product complaint. The healthcare professional reported that 15 subjects experienced the same events in the same time period after vaccination with KINRIX. At the time of reporting, no additional information was available. This is case 15 of 15 (see case IDs A0860669A, A0860688A, A0860690A - A0860701A for the other reports).
Had mild headache starting within 24 hours.  Less than 72 hours I had chills, more severe headache, body aches and fever.  Blood pressure was logged at 154/118 and pulse rate got to 155.  Dr increased blood pressure meds and beta blocker.    One day later diarrhea began and lasted for a couple of days.  A day later cold symptoms started
Positive COVID test after almost negative test; Positive COVID test after almost negative test; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 07Apr2022 at 12:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 66 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). No Known allergies. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 03Jul2022 at 12:00, outcome "not recovered" and all described as "Positive COVID test after almost negative test". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Negative, notes: Positive COVID test after almost negative test; (03Jul2022) Positive, notes: 12:00: Positive COVID test after almost negative test. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Information has been received from an office manager concerning her daughter, a 15 year old female patient with photodermatitis started in June 2009 (reported as "one year ago") who was vaccinated with the first 0.5ml dose of GARDASIL (lot # 659054/0311Y) on 05-MAR-2010 and the second 0.5ml dose on 11-MAY-2010. It was reported that the patient received GARDASIL and has since complained of aches and pains in various location of her body, headaches, and generally an ill feeling. The patient did not have injection site problems but still felt ill. The patient went to the emergency room once for dehydration and went to a chiropractor. ESR and blood work were performed, which showed sed was elevated. The patient was seeing a dermatologist in July. At the time of the report, the patient had not recovered. Additional information has been requested.
No ADE reported as of yet.  We discovered BUD date of vaccination given was 7/2/2022 after vaccination provided on site.
Patient received the Tdap vaccine into her (R) Deltoid, then the following day developed  moderate pain in the (R) side of her neck with warmth and redness. These symptoms lasted for five days following the injection. She did not get seen for this  by a doctor. Patient reported to Nursing staff one week following the vaccination. Patient did not develop swollen lymph nodes or fever. She had difficulty with ROM of he neck for five days.
Arm hurts; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 21-MAR-2023, the patient received the 1st dose of Shingles vaccine. In MAR-2023, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: Arm hurts). The outcome of the pain in arm was not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm to be related to Shingles vaccine.   Additional Information: GSK receipt date: 22-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that, thank god he/she got my first vaccine and her/him arm hurts a lot now. The follow-up could not be possible as no contact details were available. This report was one of several cases received as part of a line-listing, each containing minimal information.
7 days later, the injection site became itchy and lumpy - started looking like hives.  I put a topical cortisone cream on it to reduce the itching.  Over the next few days a red oval spot lingered with some itching, but not as bad.   I was nervous due to the week lag in reaction, but after looking online, felt comforted to know this has been occurring with other vaccine recipients.
On 4/21/2022, I woke up the next morning feeling very fatigue and it lasted most of the day. On 9/21/2022, I woke up feeling fatigue, and sinus symptoms. I thought maybe I was getting a sinus infection. I took a COVID-19 home test and it was negative. I took NYQUIL that night. On 9/22/2022, I woke up after sleeping for 12 hours and I was not feeling well and felt tired. I took a DAYQUIL at 1:00PM. I was going to work and I had to fill out a questionnaire about how I was feeling. I wrote I was having sinus problems. I took another COVID-19 home test at 4:00PM and it was positive. I went to the work and took a COVID-19 PCR test at the clinic at work, and it was positive. I came home and isolated. I called my doctor and asked for the PAXLOVID. On 9/24/2022, I got a fever of 102. I started taking the PAXLOVID on 9/24/2022. My symptoms were cough, runny nose, fatigue and my temperature. By the third dose of the PAXLOVID, I was feeling a little bit better.
. severely heavy menstrual bleeding; This is a spontaneous report from a non-contactable consumer (patient). A 33-year old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of administration, on 29May2021 14:00 (Batch/lot number unknown), at age 33 years old, as dose number unknown, single, for COVID-19 immunisation, at a pharmacy/drug store. The patient was not pregnant at the time of vaccination. Relevant medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 17Jun2021, the patient experienced severely heavy menstrual bleeding. The patient stated that it was at least double of what she has ever bled for one cycle in her life. No treatment was taken for the event. The patient recovered from the event in on an unspecified date in Jul2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I was COVID positive; I was COVID positive; Moderna Dose Number 2 / Pfizer sucrose Dose Number 3; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old male patient received BNT162b2 (BNT162B2), on 12Aug2022 at 12:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 37 years, in left arm for covid-19 immunization; elasomeran (MODERNA COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), in arm and on 12Aug2022 as dose 2, single (Batch/Lot number: unknown), in arm for covid-19 immunization. The patient's relevant medical history included: "Bi polar" (unspecified if ongoing), notes: Other medical history: Bi polar; "Known allergies: Apples" (unspecified if ongoing), notes: Known allergies: Apples; "Known allergies: pistachios" (unspecified if ongoing), notes: Known allergies: pistachios; "diabetic", start date: 09Sep2021 (unspecified if ongoing), notes: hospitalization: 5 days; not recovered; treatment: Insulin. The patient took concomitant medications. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 12Aug2022 at 12:00, outcome "unknown", described as "Moderna Dose Number 2 / Pfizer sucrose Dose Number 3"; DRUG INEFFECTIVE (hospitalization, medically significant), COVID-19 (hospitalization, medically significant), outcome "recovered" and all described as "I was COVID positive". The patient was hospitalized for drug ineffective, covid-19 (hospitalization duration: 5 day(s)). The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (17Nov2022) Negative, notes: Nasal Swab. Additional information: The patient did not receive other vaccine in four weeks and no other medication in two weeks.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Started about 3-4 hours after vaccination. Sudden Sharp pain in right hip, almost like a pinched nerve.  could not stand and put pressure on right leg until about 10 am the next day. went away just as suddenly as it appeared.  no other joints were involved. no other issues.  was not sure this was a side effect, until a friend told me she  had a similar reaction in her right shoulder ( she had her shot in her left arm).  hers lasted about 2 days.
Patient began breaking out in hives at around 3PM followed by total body chills and nausea, with no vomiting, lasting 8-12 hours. Post 8-12 hours all symptoms ceased.
Uncharacteristic difficulty retaining a set of ideas, facts, or people, after transferring to a different focus.
Three days post vax the pt died of unknown cause most likely related to severe BPD, prematurity and failure to thrive.
little bit of soreness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 59 year-old male patient received bnt162b2 (BNT162B2), administration date 20Mar2021 18:00 (Lot number: EN6208) at the age of 59 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset 20Mar2021, outcome "recovered" (Mar2021), described as "little bit of soreness".  Additional information: No Prior Vaccinations (within 4 weeks). No follow-up attempts are needed. No further information is expected.
1/1/2023 in the afternoon a scratchy throat and headache developed. Later there was a slight shortness of breath after climbing a flight of stairs. 1/2/2023 Symptoms worse with shaking chills, body aches and nasal drainage. Tested positive on an at home COVID-19 test. Televist with doctor, who proscribed PAXLOVID and to treat symptomatically. Symptoms remained the same until reporting time.
Rash on left foot, both arms and hands. Slight dizziness at times. Slight Fever has been noticed a few times, then went away. Headaches on the first day after, but not on the second day. Treatment was heat pack for head, ice packs for rashes to decrease swelling.  Also took ibuprofen
This spontaneous report was received from a nurse via company representative refers to a patient of unknown age and gender. Medical history was not reported. The nurse informed that on 16-MAY-2014 the patient was vaccinated with the first dose of GARDASIL 0.5 ml, intramuscular, (lot number and expiration date were not reported). The second dose was administered on 17-JUL-2014 and the third dose on 27-AUG-2014, according with the nurse the patient received the third dose of GARDASIL early. Also stated that the patient received the GARDASIL series according to an off label dosing schedule. No adverse effects were reported. Additional information has been requested.
falling out of bed during night time; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 81 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Parkinson" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single), for COVID-19 Immunization. The following information was reported: FALL (non-serious), outcome "unknown", described as "falling out of bed during night time". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Developed  hives 15 mins. after shot, and  shortness of breathe . Scratchy throat
THe initial intradermal administration attempt did not result in a wheel. No physical adverse event occured. The second intradermal administration was attempted by an expert and was successful.
died after taking the vaccine; This is a spontaneous report from a contactable consumer reporting on behalf of the mother. A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date, at single dose, for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient died after taking the vaccine, on an unspecified date. It was unknown if an autopsy was performed. Cause of death was unknown. The reporter believed that it was from the vaccine and ICU nurse said, doctor questioned about what the patient got sick and reporter just wanted to report it.  Information about lot/batch number has been requested.; Reported Cause(s) of Death: died after taking the vaccine
Five days after second dose, I developed left supraclavicular painful lymphadenopathy which lasted several weeks.  Ten  days after second dose, I developed massive bilateral  pulmonary emboli requiring emergent hospitalization and intervention.  Pelvic DVTs were also found.
Less than a week after taking the 2nd dose I have been experiencing Vertigo almost everyday. I have tonleave work because of it. I have been to the ER and they kept me overnight. Said I have Vertigo and sent me home. Now that I looked it up I am seeing many other posting and complaining about having Vertigo or being dizzy after getting the vaccine. I just want it to go away so I can go back to living a normal life.
I was given a flu shot at work by nurse brought in to provide the shot. I am not sure which flu vaccine it was. The next morning, the site where the shot was given was very sore. I was expecting this and didn't think anything about it. This pain lasted for months and it was so bad it kept me up at night. I finally went to the doctor who gave me a steroid shot in the arm that relieved the pain. I am who has had many shots - very big shots - and I never had a problem with them. I always had a problem with the flu shot giving me flu like symptoms but never had pain at the site of the shot before. Psychologically, I never had a problem even as a child with shots because I watched my sister (Type 1 diabetic) have shots every day. The pain was very real and significant. Given that I have very prevalent autoimmune disease in my family and I have POTS which researchers have discovered may be an autoimmune disease, I have read that having a shot could be dangerous. Never being prone to getting the flu, even as a child, I have decided to not get the flu shot until more research is done on why people are reacting badly to it.
DTAP given 06/29/2005 on right deltoid area.  07/01/2005 patient seen with swelling, erythema on right deltoid area, fever, no tenderness.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 08-APR-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (lot # reported as L040460, expiry date 27-MAY-2017; dose and route of administration were not reported). The dose was stored under temperature of 30.5 F for 47 hours and the temperature came back in range. There was no previous temperature excursion and data logger was involved. No adverse events were reported. Additional information has been requested.
On 10/9/21 patient came to the pharmacy for his second Pfizer covid-19 vaccine.  After the patient was vaccinated by pharmacist, he noticed that the patient was given 0.6ml instead of 0.3ml   The patient did NOT have an report any Adverse reaction.
Case number PHEH2012US021518 is an initial spontaneous report received from a pharmacist on 23 Oct 2012. This report refers to a 66-years-old female patient. She was vaccinated with FLUVIRIN (batch number: 1207201, expiry date: Jun 2013) intramuscularly on 19 Oct 2012. Her eye was itching 30 minutes after receiving FLUVIRIN. Her eye turned black and vision became blurry and her eyes were burning after vaccine was administered. She then rubbed her eye and then it got blurry again and was swollen. She then went to the eye doctor who said that there was a blood vessel popped in the eye. She was also feeling nauseous after a few days and still had blurred vision. The outcome of the event, blurred vision was reported as condition unchanged and that of other events were not reported.
Hard bumps (3) appeared on patients left hand 2/23/2019. Patient states only difference was that she received the SHINGRIX dose 2/21/2019. States she is not sure if it was the vaccine or that she was working in the freezer section all day on 2/21/2019. She has not reported to the doctor and is hoping they just go away.
Developed severe chest pain, admitted and found to  have myocarditis, troponin 8, cardiac cath negative
Received booster dose 10/27. Next morning, experienced severe chills. Caused muscle tension to the extent of diminished function. Has since had continuous dysregulation of temperature for x2 days; experiencing extreme heat and sweating alternating with chills. Reports feeling weak and nauseated with decreased appetite. Has noticed some improvement since initial onset of symptoms, but does continue to have difficulty controlling body temperature and sweating.
Started with cough/wheezing that would not stop. Eyes became very red. Onset of fever (99.4). Patient tried to rest but started experiencing chills and pain. Was able to sleep through night but visited doctor in the morning.
An itchy raised and red rash on his left thigh that was noticed when the patient woke up on the morning of 7/20/11.
Moderna shot 1, I have been dizzy, blurred vision, headache, dry mouth, weak, tired, heart rate racing, shaking, and just feel sore.
59 y/o female vaccinated 10/4/2010. Directly post vaccination pt. c/o a stinging sensation at the injection site. 6hrs post-vaccination pt. developed redness, bruising, swelling, tenderness (which radiated into her elbow and shoulder joint), and a large hard nodule which spread 3-4 inches around the site. Pt. reported she was given the vaccine directly out of the fridge, and believed that the temperature was a possible cause for the reaction. Pt. spoke to her friend (healthcare professional) who dx her with a vaccine reaction and told her to take BENADRYL, TYLENOL, and use hot compresses. The BENADRYL reduced the swelling, redness and swelling resolved within 7 days, but the pain remained for 30+ days. Participant as of 11/4 c/o pain upon movement, tenderness to touch in area where injection was given, and states that it aches all the time. 1st time pt. has received influenza injection, no h/o adverse reactions to vaccines.